'Pharma Bro' Shkreli gets 7 years for defrauding investors

NEW YORK (Reuters) - Martin Shkreli, the former drug company executive who made headlines by jacking up the price of a lifesaving drug before he was accused and found guilty of defrauding investors, was sentenced to 7 years on Friday.

Shkreli, 34, was sentenced by U.S. District Judge Kiyo Matsumoto in Brooklyn federal court.

(Reporting By Brendan Pierson in New York; Editing by Meredith Mazzilli)